2011-001982-42: A study of the effect of antiretroviral therapy and immunoglobulin on the HIV reservoir in Acute HIV Infection. |
|
|
| Ongoing | 4 | 10 | Europe | Octagam, Solution for infusion, Octagam | Guy's & St. Thomas' NHS Foundation Trust, Guy's & St. Thomas' Charity | Acute HIV Infection, Acute HIV Infection, Diseases [C] - Immune System Diseases [C20] | | | | |
2012-005086-12: Study to investigate the ability of a blood-derived score to select patients with relapsing multiple sclerosis who benefit from treatment with human immune globulin |
|
|
| Ongoing | 3 | 81 | Europe | Rebif 44 micrograms, Betaferon 250 microgram/ml, Extavia 250 microgram/ml, Octagam 50 mg/ml, Copaxone 20 mg/ml, Rebif 44 micrograms, Betaferon 250 microgram/ml, Extavia 250 microgram/ml, Octagam 50 mg/ml, Copaxone 20 mg/ml, Rebif 44 micrograms, Betaferon 250 microgram/ml, Extavia 250 microgram/ml | Octapharma AG, Octapharma AG | relapsing multiple sclerosis | | | | |
| Ongoing | 3 | 262 | Europe | Prednisolone (Tablet 1mg), Prednisolone (Soluble Tablet 5mg), Prednisolone (Oral Solution 10mg/ml), Human Normal Immunoglobulin (IVIg 100mg/ml), Aspirin (Dispersible Tablet 75mg), Aspirin (Tablets 300mg), Prednisolone (Tablet 5mg), Prednisolone (Tablet 10mg), Prednisolone (Tablet 2.5mg), Prednisolone (Tablet 20mg), Prednisolone (Tablet 25mg), Prednisolone (Tablet 30mg), Methylprednisolone (500mg), Methylprednisolone (1000mg), Human Normal Immunoglobulin (IVIg 50mg/ml), Aspirin (Tablet 75mg), Methylprednisolone (40mg), Methylprednisolone (125mg), Methylprednisolone (2g), B01AC06, Tablet, Soluble tablet, Oral solution, Solution for injection/infusion, Dispersible tablet, Powder and solvent for solution for injection/infusion, Powder for injection, Asaflow (80mg), Aspirine (100mg), Aspegic 100mg, Cardioaspirine (100mg), Solu-Medrol S.A.B. (40mg), Octagam (50 mg/ml) solution for infusion, Octagam 10% solution for infusion, Privigen 100 mg/ml solution for infusion, Iqymune (100mg/mL), Okrido 6mg/ml drank | MRC CTU at UCL, Medical Research Council Clinical Trials Unit at University College London, UNIVERSITY COLLEGE LONDON, MRC Clinical Trials Unit at University College London (UCL), Innovative Medicines Initiative 2 Joint Undertaking, Innovative Medicines Initiative 2, Innovative Medicine Initiative 2 Joint Undertaking | Kawasaki Disease, Kawasaki Disease, Diseases [C] - Cardiovascular Diseases [C14] | | | | |
| Recruiting | 3 | 272 | Europe | Neofordex®, Dexamethasone, Intravenous immunoglobulins, Tegeline®, Clayrig®,, Gammagard®,, Octagam®,, Privigen®,, Other IgIV patent medicine | Assistance Publique - Hôpitaux de Paris | Immune Thrombocytopenia (ITP) | 04/25 | 10/26 | | |